p53 mutations in Type II tumors lead to the loss of a key tumor suppressor, and SIRT1 exacerbates this issue by deacetylating and inactivating p53, allowing tumor cells to escape apoptosis. The gene discussed is SIRT1; the disease is neoplasm.